key: cord-0813894-g938627w
authors: Watanabe, Jonathan H.; Kwon, Jimmy; Mehta, Sanjay R.
title: Association of Age and Hospitalization Amongst Those with Underlying High-risk Conditions at COVID-19 Diagnosis in a Large, State-wide Health System
date: 2021-06-16
journal: J Gen Intern Med
DOI: 10.1007/s11606-021-06942-y
sha: 2b98444ad2ba78b9dc552cfde0eb388145f0a16f
doc_id: 813894
cord_uid: g938627w

nan

Data for 25,834 patients with SARS-CoV-2 infection, diagnosed by RNA nucleic acid amplification, were analyzed for March 10, 2020, through January 14, 2021, from the University of California COVID Research Data Set (UC CORDS). UC CORDS contains SARS-CoV-2 testing results and COVID-19 treatment information collected from across University of California (UC) Health and is distributed weekly for research purposes. Per UC Health reporting, patients were designated as having a COVID-19-related hospitalization if admitted within 30-days of diagnosis or tested positive during the stay. Presence of high-risk conditions hypertension, hyperlipidemia, heart disease, type 2 diabetes, cancer, asthma/ chronic obstructive pulmonary disorder (COPD), chronic kidney disease (CKD), and end-stage renal disease (ESRD) was determined using the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes in the electronic health record (EHR). A combined cardiovascular risk factors category that included patients with hypertension, hyperlipidemia, or heart disease was also assessed. Preexisting conditions included ICD-10-CM codes up to one-year preceding COVID-19 diagnosis. Multiple logistic regression was used for estimation of odds ratios. Exposure variables were older adult categories defined as 65 to 74 years old and >75 years old. Outcome variable was COVID-19related hospitalization. Adjustment variables were gender and race/ethnicity extracted from EHR. All analyses performed in R, version 3.6.3 (R Project for Statistical Computing). Statistical significance set at level of alpha = 0.05. UC CORDS was operationalized by UC Health as "non-human subjects research" and analyses are considered institutional review board exempt.

The mean [SD] age of the study population was 42.4 [20.6] years. The sample was 53% female, 43% were White, 22% non-White Hispanic, 7% Asian, 6% Black, and 44% reported as "Other" (Table 1) . For each high-risk condition group, those 65 to 74 years old and >75 were at increased odds of hospitalization compared to patients < 65. All differences between older adult categories and <65 reference category were statistically significant except for heart disease and cancer in the 65- (Fig. 1) .

In this analysis of COVID-19-positive patients in a large, diverse, state-wide health system, adults >65 years with underlying highrisk conditions were much more likely to be hospitalized following SARS-CoV-2 infection than younger patients with high-risk conditions adjusted for gender and race/ethnicity. The observational nature of this study precludes confirmation of a cause and effect relationship between age and hospitalization, but rather demonstrated an association between older age and hospitalization. As of April 15, 2021, COVID-19 vaccination is available to all adults in the USA. 2 However, a significant portion of the highest risk population (adults >65 years old and adults with high-risk conditions) remain unvaccinated accompanied by a troubling slowing rate of vaccination in older adults. 3 As cases and hospitalizations persist 4 and highly transmissible SARS-CoV-2 variants gain dominance, 5 outreach efforts to vaccinate these high-risk unvaccinated individuals is critical. We will need to rethink our vaccination strategies to significantly improve convenience and outreach to reach this population. Full vaccination (i.e., 2 doses of the mRNA-based vaccines) of this population is crucial to ensure this most vulnerable population is protected as rapidly as possible. Furthermore, in the high-risk individuals that become infected with SARS-CoV-2, we should prioritize monoclonal antibody therapies, which have shown a benefit in these persons. 6 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons. org/licenses/by/4.0/.

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet

The Advisory Committee on Immunization Practices' Updated Interim Recommendation for Allocation of COVID-19 Vaccine -United States

Centers for Disease Control and Prevention

Johns Hopkins Coronavirus Resource Center

Centers for Disease Control and Prevention

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial